These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 6431431)

  • 1. Effect of phospholipid on factor VIII inactivation.
    Barrowcliffe TW; Kemball-Cook G; Gray E
    Prog Clin Biol Res; 1984; 150():251-63. PubMed ID: 6431431
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding to phospholipid protects factor VIII from inactivation by human antibodies.
    Barrowcliffe TW; Kemball-Cook G; Gray E
    J Lab Clin Med; 1983 Jan; 101(1):34-43. PubMed ID: 6401316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between a serum fraction and FEIBA fraction in haemophilia.
    Hutton RA; Dormandy K; Nour-Eldin F
    New Istanbul Contrib Clin Sci; 1980; 13(1):9-22. PubMed ID: 6774316
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hemophiliacs with inhibitors].
    Fujimaki M
    Rinsho Ketsueki; 1985 Jul; 26(7):1059-68. PubMed ID: 3932719
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibitor hemophilia in oral surgery].
    Schulz S
    Zahn Mund Kieferheilkd Zentralbl; 1984; 72(8):824-8. PubMed ID: 6240865
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhibitors and "bypass" therapy in hemophilia].
    Fukutake K; Fukutake K
    Nihon Rinsho; 1981; 39(12):3688-99. PubMed ID: 6803034
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemophiliacs with inhibitors: therapeutic options.
    Roberts HR
    N Engl J Med; 1981 Sep; 305(13):757-8. PubMed ID: 6790992
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhibitors (antibodies) directed against factor VIII in hemophilia A (author's transl)].
    Beck EA
    Ther Umsch; 1979 Apr; 36(4):326-9. PubMed ID: 377556
    [No Abstract]   [Full Text] [Related]  

  • 9. New alternatives and strategies in the treatment of inhibitors.
    Hoyer LW
    Prog Clin Biol Res; 1984; 150():367-72. PubMed ID: 6431440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple inhibitor screen is more sensitive than a Bethesda assay in monitoring for the development of inhibitors in haemophilia A and B.
    Keeling D; Beavis J; Sukhu K
    Br J Haematol; 2005 Mar; 128(6):885. PubMed ID: 15755295
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of immuninhibitor hemophilia A with FEIBA plasma fraction].
    István L; Bariska I; Marton E
    Orv Hetil; 1980 Dec; 121(51):3131-5. PubMed ID: 6784062
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of factor VIII by factor IXa.
    Rick ME
    Blood; 1982 Sep; 60(3):744-51. PubMed ID: 6809077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor development in patients with hemophilia: an overview.
    Leissinger CA
    Semin Hematol; 2006 Apr; 43(2 Suppl 4):S1-2. PubMed ID: 16690370
    [No Abstract]   [Full Text] [Related]  

  • 14. [Importance of PPSB fraction in the treatment of hemophilia A with antibodies against factor VIII].
    Hrubisková K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(4):672-82. PubMed ID: 6162735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of coagulation factor VIII inhibitors].
    Lutze G; Schlote A; Mittler U
    Z Gesamte Inn Med; 1980 Apr; 35(8):330-6. PubMed ID: 6776700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII inhibitors: a continuing problem.
    Hoyer LW
    J Lab Clin Med; 1993 Mar; 121(3):385-7. PubMed ID: 8445287
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficiency and limits of immunologic methods in the diagnosis of blood coagulation].
    Schwick HG; Trobisch H; Heimburger N
    Internist (Berl); 1973 Apr; 14(4):160-9. PubMed ID: 4197663
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of the procoagulant activities of factor IX concentrates.
    Mackie IJ; Seghatchian MJ
    Thromb Res; 1982 Nov; 28(4):499-507. PubMed ID: 6819651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor.
    Fukui H; Fujimura Y; Takahashi Y; Mikami S; Yoshioka A
    Thromb Res; 1981 Apr 1-15; 22(1-2):177-84. PubMed ID: 6794176
    [No Abstract]   [Full Text] [Related]  

  • 20. Activated ppsb in the treatment of a patient with haemophilia and antibodies to factor VIII.
    Ekert H; McVeagh P
    Med J Aust; 1975 Oct; 2(17):675-7. PubMed ID: 1207551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.